Viemed Healthcare, INC

Viemed Healthcare announced record net revenues of $78.1 million for the second quarter of 2026, driven by significant growth in ventilator and PAP therapy patients, and has raised its full-year revenue guidance.

Viemed Healthcare's shareholders approved a second amendment to its 2024 Long Term Incentive Plan, increasing the share reserve and ratified the appointment of Ernst & Young LLP as auditors.

Viemed Healthcare Inc. presented its investor deck for June 2026, highlighting robust financial performance, strategic expansion into new service lines, and a strong outlook driven by industry tailwinds.

Viemed Healthcare reports strong Q1 2026 results with 28% revenue growth and updated full-year guidance, driven by diversification and capital efficiency.

Viemed Healthcare, Inc. highlights record 2025 financial results and provides robust 2026 guidance, driven by diversified home-based clinical care services and strategic growth initiatives.

Viemed Healthcare reported record financial results for 2025, driven by strong organic growth and acquisitions, and announced a new share repurchase program.

Viemed Healthcare Inc. announced its second-quarter 2026 financial results, showcasing a 23.9% increase in revenue driven by strong performance across rental, sales, and service segments, despite a slight dip in net income due to increased operating expenses.

Viemed Healthcare reported Q1 2026 revenue of $75.4 million, a 27.5% increase year-over-year, driven by strong equipment sales and service expansion.

Viemed Healthcare, Inc. announced robust revenue growth for the third quarter and year-to-date 2025, driven by strategic acquisitions and expansion of its home medical equipment and services.

Viemed Healthcare, Inc. reported significant revenue and net income growth for the second quarter of 2025, driven by increased patient volumes and diversified service offerings.

Viemed Healthcare's Q1 2025 revenue increased by 16.9% year-over-year, fueled by growth in ventilator rentals and strategic expansion.

Viemed Healthcare saw a 17.4% increase in revenue in the third quarter of 2024, primarily driven by growth in ventilator rentals and healthcare staffing services.

Viemed Healthcare reported 20.5% revenue growth and a 34.8% rise in net income for 2025, expanded via acquisitions, resupply programs, and home respiratory care, while authorizing a new 2026 share buyback.

Viemed Healthcare's 2024 annual report reveals revenue growth and strategic advancements in home medical equipment and respiratory care services.

Viemed Healthcare, Inc.'s 10-K filing outlines the company's share structure, regulatory compliance, and financial performance for the year ended December 31, 2023.

Viemed Healthcare's Chief Medical Officer, William Frazier, reported transactions involving the acquisition and disposition of common shares and stock options.

Viemed Healthcare Director Timothy Smokoff reported a series of stock sales on June 24, 2026, totaling 15,364 common shares.

Viemed Healthcare President Michael Moore sold 136,802 common shares indirectly through Moore Faster LLC in mid-March 2026.

Viemed Healthcare CEO Casey Hoyt reported the vesting of restricted stock units and phantom share units, leading to an increase in direct beneficial ownership after tax withholdings and cash settlements.

Viemed Healthcare's VP of Sales, Jerome Cambre, reported the vesting and settlement of restricted stock units and phantom shares.

Viemed Healthcare President Michael Moore reported the vesting of restricted stock and phantom share units, alongside tax-related share dispositions.

Viemed Healthcare, Inc. has issued its 2026 proxy statement, seeking shareholder approval for director elections, auditor reappointment, and an increase in shares for its 2024 Long Term Incentive Plan.

Viemed Healthcare will hold its annual general and special meeting of shareholders on June 5, 2025, to discuss key corporate matters including financial statements, director elections, auditor appointment, and executive compensation.

Viemed Healthcare is holding its annual general and special meeting on June 5, 2025, to vote on key proposals including amendments to the long-term incentive plan, executive compensation, and the re-appointment of Ernst & Young LLP as auditors.

Viemed Healthcare will hold its 2024 annual general and special meeting on June 6, 2024, to discuss financial statements, elect directors, appoint auditors, and ratify the 2024 Long Term Incentive Plan.

Viemed Healthcare will hold its annual general and special meeting on June 6, 2024, to discuss audited financials, elect directors, appoint auditors, and ratify the 2024 Long Term Incentive Plan.

Forager Capital Management, LLC and its affiliates have reported beneficial ownership of 4.9% of Viemed Healthcare, Inc. common stock.

Forager Capital Management and affiliates disclose 7.2% beneficial ownership in Viemed Healthcare, Inc.

BlackRock Portfolio Management LLC has disclosed a 6.4% beneficial ownership stake in Viemed Healthcare, Inc., holding 2,540,114 shares of common stock as of June 30, 2025.

Forager Capital Management, along with its affiliated fund and principals, has disclosed a passive 5.5% beneficial ownership stake in Viemed Healthcare, Inc. through a Schedule 13G filing.

Thrivent Financial for Lutherans has filed an Amendment No. 5 to Schedule 13G, disclosing a beneficial ownership of 2,705,000 shares, representing 6.8% of Viemed Healthcare, Inc.'s common stock as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 5.8% of Viemed Healthcare, Inc.'s common stock as of March 31, 2025.